Michael Berk
Affiliations: | University of Melbourne, Parkville, Victoria, Australia |
Area:
Bipolar Disorder, Psychoharmacology, Early Psychosis, Telemedicine,Google:
"Michael Berk"Mean distance: 15.95 (cluster 29)
Children
Sign in to add traineeFrancesco M. S. Giorlando | grad student | 2008- | University of Melbourne |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Anmella G, Meehan A, Ashton M, et al. (2023) Exploring Clinical Subgroups of Participants with Major Depressive Disorder that may Benefit from Adjunctive Minocycline Treatment. Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology. 22: 33-44 |
Sarmiento A, Dean OM, Kavanagh BE, et al. (2023) The Influence of Personality Disorder Symptoms on Treatment Outcomes in Bipolar Disorder: A Secondary Analysis of a Randomised Controlled Trial. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 7067437231213558 |
Schwartz OS, Amminger P, Baune BT, et al. (2023) The Study of Ketamine for Youth Depression (SKY-D): study protocol for a randomised controlled trial of low-dose ketamine for young people with major depressive disorder. Trials. 24: 686 |
McIntyre RS, Alsuwaidan M, Baune BT, et al. (2023) Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 22: 394-412 |
Marx W, Penninx BWJH, Solmi M, et al. (2023) Major depressive disorder. Nature Reviews. Disease Primers. 9: 44 |
Russell SE, Wrobel AL, Ashton MM, et al. (2023) Does Post-traumatic Stress Disorder Impact Treatment Outcomes within a Randomised Controlled Trial of Mitochondrial Agents for Bipolar Depression? Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology. 21: 457-465 |
Khanra S, Reddy P, Giménez-Palomo A, et al. (2023) Metabolic regulation to treat bipolar depression: mechanisms and targeting by trimetazidine. Molecular Psychiatry |
Russell SE, Skvarc DR, Mohebbi M, et al. (2023) The Impact of -acetylcysteine on Major Depression: Qualitative Observation and Mixed Methods Analysis of Participant Change during a 12-week Randomised Controlled Trial. Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology. 21: 320-331 |
Wrobel AL, Russell SE, Jayasinghe A, et al. (2023) Interpersonal Trauma and Depression Severity Among Individuals With Bipolar Disorder: Findings From the Prechter Longitudinal Study of Bipolar Disorder. The Journal of Clinical Psychiatry. 84 |
Panizzutti B, Skvarc D, Lin S, et al. (2023) Minocycline as Treatment for Psychiatric and Neurological Conditions: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. 24 |